Acquired Resistance to Antibody-Drug Conjugates

by Denis M. Collins, Birgit Bossenmaier, Gwendlyn Kollmorgen, Gerhard Niederfellner
Published 2019-03-01

Structural requirements for cub domain containing protein 1 (CDCP1) and Src dependent cell transformation.

by Gwendlyn Kollmorgen, Birgit Bossenmaier, Gerhard Niederfellner, Hans-Ulrich Häring, Reiner Lammers
Published 2012-01-01

Deciphering the stepwise binding mode of HRG1β to HER3 by surface plasmon resonance and interaction map.

by Carmen Peess, Leopold von Proff, Sabine Goller, Karl Andersson, Michael Gerg, Magnus Malmqvist, Birgit Bossenmaier, Michael Schräml
Published 2015-01-01

Direct estrogen receptor (ER) / HER family crosstalk mediating sensitivity to lumretuzumab and pertuzumab in ER+ breast cancer.

by Denis Collins, Wolfgang Jacob, Juan Miguel Cejalvo, Maurizio Ceppi, Ian James, Max Hasmann, John Crown, Andrés Cervantes, Martin Weisser, Birgit Bossenmaier
Published 2017-01-01

Translation and evaluation of a pre-clinical 5-protein response prediction signature in a breast cancer phase Ib clinical trial.

by Axel Ducret, Ian James, Sabine Wilson, Martina Feilke, Andreas Tebbe, Nikolaj Dybowski, Sarah Elschenbroich, Martin Klammer, Adele Blackler, Wei-Li Liao, Yuan Tian, Thomas Friess, Birgit Bossenmaier, Gabriele Dietmann, Christoph Schaab, Todd Hembrough, Maurizio Ceppi
Published 2019-01-01

Characterization of a re‐engineered, mesothelin‐targeted Pseudomonas exotoxin fusion protein for lung cancer therapy

by Frieder Bauss, Martin Lechmann, Ben-Fillippo Krippendorff, Roland Staack, Frank Herting, Matthias Festag, Sabine Imhof-Jung, Friederike Hesse, Marc Pompiati, Gwendlyn Kollmorgen, Rita da Silva Mateus Seidl, Birgit Bossenmaier, Wilma Lau, Christian Schantz, Jan O. Stracke, Ulrich Brinkmann, Masanori Onda, Ira Pastan, Klaus Bosslet, Gerhard Niederfellner
Published 2016-10-01